These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 18698253)

  • 21. Isotype-specific detection of ABO blood group antibodies using a novel flow cytometric method.
    Stussi G; Huggel K; Lutz HU; Schanz U; Rieben R; Seebach JD
    Br J Haematol; 2005 Sep; 130(6):954-63. PubMed ID: 16156865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interinstitutional variation in the measurement of anti-A/B antibodies: the Japanese ABO-Incompatible Transplantation Committee survey.
    Tanabe K
    Transplantation; 2007 Dec; 84(12 Suppl):S13-6. PubMed ID: 18162979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flow cytometric measurement of ABO antibodies in ABO-incompatible living donor kidney transplantation.
    Yung GP; Valli PV; Starke A; Mueller RJ; Fehr T; Cesar-Ozpamir M; Schanz U; Weber M; Wüthrich RP; Seebach JD; Stussi G
    Transplantation; 2007 Dec; 84(12 Suppl):S20-3. PubMed ID: 18162982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid and accurate measurement of anti-A/B IgG antibody in ABO-unmatched living donor liver transplantation by surface plasmon resonance.
    Yurugi K; Kimura S; Ashihara E; Tsuji H; Kawata A; Kamitsuji Y; Hishida R; Takegawa M; Egawa H; Maekawa T
    Transfus Med; 2007 Apr; 17(2):97-106. PubMed ID: 17430465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flow cytometric detection of anti-AB antibody titers in blood group O recipients of blood group A2 donor kidneys.
    Ata P; Cetinkaya F; Ozgezer T; Ozel L; Tulunay A; Eksioglu E; Titiz MI
    Transplant Proc; 2012; 44(6):1706-9. PubMed ID: 22841249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of flow cytometry to monitor antibody levels in ABO incompatible kidney transplantation.
    Krishnan NS; Fleetwood P; Higgins RM; Hathaway M; Zehnder D; Mitchell D; Hamer R; Fletcher S; Lam FT; Kashi H; Tan LC; Imray C; Briggs D
    Transplantation; 2008 Aug; 86(3):474-7. PubMed ID: 18698253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ABO incompatible kidney transplantation.
    Gloor JM; Stegall MD
    Curr Opin Nephrol Hypertens; 2007 Nov; 16(6):529-34. PubMed ID: 18089966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Detection of antibodies specific for blood group antigens A and B].
    Yurugi K; Kimura S; Maekawa T
    Rinsho Byori; 2005 Nov; 53(11):1011-8. PubMed ID: 16372751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Japan's experience with living-donor kidney transplantation across ABO barriers.
    Ichimaru N; Takahara S
    Nat Clin Pract Nephrol; 2008 Dec; 4(12):682-92. PubMed ID: 18941430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The blood group incompatible living kidney transplantation].
    Donauer J
    MMW Fortschr Med; 2007 Aug; 149(31-32):27-8. PubMed ID: 17849782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ABO-incompatible kidney transplantation with antigen-specific immunoadsorption and rituximab - insights and uncertainties.
    Geyer M; Fischer KG; Drognitz O; Walz G; Pisarski P; Wilpert J
    Contrib Nephrol; 2009; 162():47-60. PubMed ID: 19001813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic strategies in management of the highly HLA-sensitized and ABO-incompatible transplant recipients.
    Jordan SC; Peng A; Vo AA
    Contrib Nephrol; 2009; 162():13-26. PubMed ID: 19001810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Solid phase techniques in blood group serology].
    Uthemann H; Sturmfels L; Lenhard V
    Infusionsther Transfusionsmed; 1993 Jun; 20 Suppl 2():47-51. PubMed ID: 8374289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conquering absolute contraindications to transplantation: positive-crossmatch and ABO-incompatible kidney transplantation.
    Dean PG; Gloor JM; Stegall MD
    Surgery; 2005 Mar; 137(3):269-73. PubMed ID: 15746773
    [No Abstract]   [Full Text] [Related]  

  • 35. ABO-incompatible living donor liver transplantation: new insights into clinical relevance.
    Kawagishi N; Satomi S
    Transplantation; 2008 Jun; 85(11):1523-5. PubMed ID: 18551048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The pretransfusion bedside agglutination test is not a "Gold Standard"].
    Levy G
    Transfus Clin Biol; 2008 Nov; 15(5):318-21. PubMed ID: 18930684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of non-donor-specific HLA antibodies after kidney transplantation: frequency and clinical implications.
    Briggs D; Zehnder D; Higgins RM
    Contrib Nephrol; 2009; 162():107-16. PubMed ID: 19001818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody-mediated rejection: treatment alternatives and outcomes.
    Singh N; Pirsch J; Samaniego M
    Transplant Rev (Orlando); 2009 Jan; 23(1):34-46. PubMed ID: 19027615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electronic crossmatching.
    Arslan O
    Transfus Med Rev; 2006 Jan; 20(1):75-9. PubMed ID: 16373190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The value of DNA analysis for antigens of the Kidd blood group system.
    Lomas-Francis C
    Transfusion; 2007 Jul; 47(1 Suppl):23S-7S. PubMed ID: 17593282
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.